Saturday, January 31, 2026
26.9 C
Bengaluru

What’s the Mood of Indian Pharma? A Poll by MedicinMan

We are in the middle of huge crisis and uncertainty. The Covid-19 crisis is taking a toll on Indian Pharma Leaders. Many leaders are not sure – what is of critical importance at this time? What are they are supposed to do and how they are supposed to do it? There are enormous challenges that majority of leaders have not faced before.

  • Many leaders had to take a pay-cut, downsize their teams, and deliver bad news up and down the organization.
  • Working from home for months and feeling stressed because there is no light at the end of the tunnel.
  • What can you do to stay focused and upbeat during this prolonged uncertain time?
  • How can you learn to reframe the situation that you are facing?
  • Who can you vent your frustration and feelings to? And, what can you do to recharge when most of your usual outlets are not available?

Leading effectively — especially during a crisis, needs emotional maturity and patience. If you can’t retain your cool and composure in the face of frustration and adversity, you won’t be able to keep others in your team, calm.

While this is really difficult, how can we change our focus and think about it differently?

This is probably the biggest growth opportunity that you will ever have in your career, if only you can manage through this and make sure your team weather this storm. Let’s discover the power of emotional intelligence in leadership, and challenge how leaders can develop this competency to not only improve self-management but also handle interpersonal relationships judiciously and empathetically.

Get an insight into the Emotional State of Indian Pharma professionals at the Digital Excellence Pharma Academy.

Register now for our webinar, “Leading with Emotional Intelligence” by Deep Bhandari on Wednesday 23rd September on https://www.credoweb.in/discussion/558/leading-with-emotional-intelligence?anchor=1167

Hot this week

IQVIA vs. PharmaTrac: Indian Pharma Market Data

Here is an analytical blog comparing the IQVIA MFR...

Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead

The latest PharmaTrac report for December 2025 offers a...

Orphan Drugs and Indian Pharma: Moving from Volume to Value?

Zydus’ ZYCUBO May Be the Proof Point the Industry...

Arjun Arunachalam: The Man Who Deleted Helium

For more than fifty years, the MRI industry treated...

Who Is Monitoring Quality in India’s Small Drug Units?

The Telangana Drugs Control Administration’s stop-use notice on a...

Topics

IQVIA vs. PharmaTrac: Indian Pharma Market Data

Here is an analytical blog comparing the IQVIA MFR...

Orphan Drugs and Indian Pharma: Moving from Volume to Value?

Zydus’ ZYCUBO May Be the Proof Point the Industry...

Arjun Arunachalam: The Man Who Deleted Helium

For more than fifty years, the MRI industry treated...

Who Is Monitoring Quality in India’s Small Drug Units?

The Telangana Drugs Control Administration’s stop-use notice on a...

Zydus vs. Helsinn — What It Really Means for Indian Pharma

On December 24, 2025, the Delhi High Court delivered...

Worldclass Healthcare But Out of Reach for Most Indians?

When an eminent cardiologist like Dr. Sunil Chandy—former Director...

Managed Healthcare – Better Choice for India?

Managed care shifts healthcare from fragmented fee-for-service models to...
spot_img

Related Articles

spot_imgspot_img